您的位置: 首页 > 农业专利 > 详情页

Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors
专利权人:
Inc.;Regeneron Pharmaceuticals
发明人:
Harikiran Nistala,Cristopher Van Hout,Lyndon Mitnaul,Anthony Marcketta
申请号:
US16816515
公开号:
US20200297751A1
申请日:
2020.03.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present disclosure provides methods of treating subjects having increased serum glucose level and/or hyperglycemia, methods of identifying subjects having an increased risk of developing increased serum glucose level and/or hyperglycemia, and methods of detecting human Solute Carrier Family 39 Member 5 variant nucleic acid molecules and variant polypeptides.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充